219 related articles for article (PubMed ID: 17380268)
21. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.
Maher S; McClean S
Biochem Pharmacol; 2006 Apr; 71(9):1289-98. PubMed ID: 16530733
[TBL] [Abstract][Full Text] [Related]
22. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
23. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
24. Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin.
Yang T; Arnold JJ; Ahsan F
J Drug Target; 2005 Jan; 13(1):29-38. PubMed ID: 15848952
[TBL] [Abstract][Full Text] [Related]
25. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
[TBL] [Abstract][Full Text] [Related]
26. Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer.
Petersen SB; Nielsen LG; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2013 Mar; 48(4-5):726-34. PubMed ID: 23354154
[TBL] [Abstract][Full Text] [Related]
27. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.
Pontier C; Pachot J; Botham R; Lenfant B; Arnaud P
J Pharm Sci; 2001 Oct; 90(10):1608-19. PubMed ID: 11745719
[TBL] [Abstract][Full Text] [Related]
28. Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae.
McCartney F; Perinelli DR; Tiboni M; Cavanagh R; Lucarini S; Filippo Palmieri G; Casettari L; Brayden DJ
Int J Pharm; 2021 May; 601():120593. PubMed ID: 33857587
[TBL] [Abstract][Full Text] [Related]
29. Phospholipase A2 and mediation of the activation of short-circuit current in the rat colonic mucosa.
Diener M; Rummel W
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):652-8. PubMed ID: 1944607
[TBL] [Abstract][Full Text] [Related]
30. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
33. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
34. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
35. CriticalSorb™ promotes permeation of flux markers across isolated rat intestinal mucosae and Caco-2 monolayers.
Brayden DJ; Bzik VA; Lewis AL; Illum L
Pharm Res; 2012 Sep; 29(9):2543-54. PubMed ID: 22638869
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability.
Kamei N; Yamanaka J; Oda Y; Kaneoka S; Koide Y; Haruna Y; Takahashi Y; Tamiwa H; Takeda-Morishita M
Pharm Res; 2020 Sep; 37(10):182. PubMed ID: 32888051
[TBL] [Abstract][Full Text] [Related]
37. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
38. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
[TBL] [Abstract][Full Text] [Related]
39. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
40. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.
Feighery LM; Cochrane SW; Quinn T; Baird AW; O'Toole D; Owens SE; O'Donoghue D; Mrsny RJ; Brayden DJ
Pharm Res; 2008 Jun; 25(6):1377-86. PubMed ID: 18163202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
